| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||
Net loss | |||||||||
-25,124 | -36,256 | -15,191 | -11,985 | 6,668 | 5,251 | -84 | -3,927 | - | - |
Reconciliation of net loss to net cash provided by (used in) operating activities: | |||||||||
Net loss | |||||||||
- | - | - | - | - | - | - | - | -3,007 | -3,423 |
Depreciation of fixed assets | |||||||||
3,700 | 2,600 | 1,700 | 900 | 560 | 415 | 375 | 357 | 319 | 276 |
Amortization of debt discount | |||||||||
- | - | - | - | 6,680 | 261 | 0 | 0 | - | - |
Gain on sale of assets | |||||||||
0 | 20 | 0 | 0 | - | - | - | - | - | - |
Amortization of license fee | |||||||||
- | - | - | - | 100 | 100 | 100 | - | - | - |
Provision for write down of inventory | |||||||||
-459 | 1,363 | 2,132 | 1,400 | 50 | 228 | 110 | 138 | 180 | 430 |
Amortization of product acquisition costs | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Provision for bad debt | |||||||||
-428 | 452 | 1,767 | 327 | 0 | - | - | - | 6 | - |
Issuance of stock to consultant | |||||||||
0 | 102 | 0 | 189 | 0 | 80 | 0 | - | - | - |
Stock based compensation | |||||||||
1,076 | 1,970 | 3,295 | 2,999 | 2,273 | 823 | 536 | 378 | - | - |
Stock-based compensation expense | |||||||||
- | - | - | - | - | - | - | - | 351 | 501 |
Amortization of debt costs and debt discount | |||||||||
6,514 | 9,226 | 9,586 | 8,427 | 1,132 | 107 | 31 | 862 | 161 | 4 |
Amortization of intangibles | |||||||||
3,000 | 3,100 | 2,900 | 2,800 | 514 | 120 | 60 | 100 | 100 | 100 |
Non cash lease expense | |||||||||
408 | 0 | - | - | - | - | - | - | - | - |
Non cash lease expense | |||||||||
408 | 0 | - | - | - | - | - | - | - | - |
Deferred income taxes | |||||||||
-22 | 73 | 0 | 0 | - | - | - | - | - | - |
Foreign currency exchange loss (gain) | |||||||||
-1,523 | -3,371 | 7,719 | -936 | 109 | 0 | 0 | - | - | - |
Partial extinguishment of 3.75% senior notes | |||||||||
185 | 4,235 | 0 | 0 | - | - | - | - | - | - |
Non cash interest expense | |||||||||
8,464 | 0 | - | - | - | - | - | - | - | - |
Extinguishment of prior term loan | |||||||||
0 | 1,315 | 0 | 0 | - | - | - | - | - | - |
Loss on impairment of intangible assets | |||||||||
0 | 1,924 | 113 | 16 | - | - | - | - | - | - |
Loss on debt restructuring | |||||||||
-920 | 0 | - | - | - | - | - | - | - | - |
Change in the fair value of derivative liability | |||||||||
6,769 | 0 | - | - | - | - | - | - | - | - |
Change in the fair value of derivative liability | |||||||||
- | - | - | - | 23,144 | 2,300 | 0 | 0 | - | - |
Loss on disposal of property/impairment | |||||||||
- | - | - | - | 0 | - | - | - | - | - |
Loss on disposal of property | |||||||||
- | - | - | - | - | 0 | 0 | -9 | - | - |
Changes in operating assets and liabilities: | |||||||||
Accounts receivable | |||||||||
3,655 | 4,047 | -5,964 | 7,936 | -1,250 | 9,419 | 3,370 | 369 | -399 | -53 |
Licensing and royalty income receivable | |||||||||
- | - | - | - | - | - | - | - | - | 46 |
Inventories | |||||||||
6,145 | 1,877 | 5,275 | 5,042 | 3,578 | 143 | 1,206 | 716 | -559 | -372 |
Prepaid expenses and other current receivables | |||||||||
-803 | -224 | 748 | -3,427 | 5,408 | 1,075 | 402 | -119 | 55 | -291 |
Other assets | |||||||||
-12 | 26 | -192 | -667 | 14 | 0 | 0 | - | - | - |
Operating liabilities | |||||||||
-369 | 0 | - | - | - | - | - | - | - | - |
Accounts payable and accrued expenses | |||||||||
377 | -3,405 | 1,641 | 2,825 | -2,849 | 2,346 | 2,528 | 671 | 424 | -147 |
Deferred income | |||||||||
-2,426 | 2,426 | 0 | -476 | - | - | - | - | - | - |
Deferred income | |||||||||
- | - | - | - | 362 | -685 | 704 | 5 | -25 | -84 |
Net cash used in operating activities | |||||||||
-18,419 | -13,275 | 398 | -447 | - | - | - | - | -2,394 | -3,013 |
Net cash used in operating activities | |||||||||
- | - | - | - | -15,513 | -3,891 | -618 | -2,373 | - | - |
Cash flows from investing activities: | |||||||||
Capital expenditures | |||||||||
8,203 | 25,332 | 40,429 | 16,655 | 5,998 | 834 | 287 | 342 | 350 | 158 |
Disposal of fixed assets | |||||||||
0 | 38 | 0 | 0 | - | - | - | - | - | - |
Acquisition of product rights and other related assets | |||||||||
- | - | - | - | 35,418 | 0 | 0 | - | - | - |
Product acquisition costs, net | |||||||||
- | - | 0 | 3,421 | 11,652 | 2,958 | 1,826 | 0 | - | - |
Repayment of note payable, related party | |||||||||
- | - | - | - | - | - | 0 | 500 | 500 | - |
(Expenses of) proceeds from sale of treasury stock, net of expenses | |||||||||
- | - | - | - | - | - | -63 | 1,963 | - | - |
Deposits for capital expenditures | |||||||||
- | - | - | - | - | - | - | - | - | 37 |
Net cash used in investing activities | |||||||||
-8,203 | -25,294 | -40,429 | -20,076 | - | - | - | - | -350 | -195 |
Net cash used in investing activities | |||||||||
- | - | - | - | -53,068 | -3,792 | -2,113 | -342 | - | - |
Cash flows from financing activities: | |||||||||
Proceeds from 2023 Series B senior notes | |||||||||
17,750 | 0 | - | - | - | 138,985 | 0 | 0 | - | - |
Proceeds from 2023 Series B bifurcated conversion option | |||||||||
11,525 | 0 | - | - | - | - | - | - | - | - |
Proceeds from exercise of common stock options | |||||||||
- | - | - | - | - | - | - | - | 74 | 12 |
Proceeds from revolver | |||||||||
12,500 | 15,000 | 0 | 0 | - | - | - | - | - | - |
Repayment of revolver | |||||||||
2,500 | 0 | - | - | - | - | - | - | - | - |
Repayment of prior term loan, net | |||||||||
0 | 25,550 | - | - | - | - | - | - | - | - |
Repayment of 3.75% senior notes | |||||||||
13,022 | 0 | - | - | - | - | - | - | - | - |
Repayment of 2021 term loan, net | |||||||||
- | - | 0 | 0 | - | - | - | - | - | - |
Payment (recovery) from stockholder, net | |||||||||
- | - | - | - | 19 | 0 | 0 | - | - | - |
Excess tax benefits from stock compensation | |||||||||
- | - | - | - | - | 94 | 0 | 0 | - | - |
Debt issuance costs | |||||||||
3,107 | 6,239 | 0 | 0 | - | - | - | - | - | - |
Repurchase of 3.75% senior notes | |||||||||
2,686 | 53,123 | - | - | - | - | - | - | - | - |
Proceeds from issuance of stock, net | |||||||||
- | - | - | - | -3 | 24,858 | - | - | - | - |
Proceeds from issuance of stock, net | |||||||||
- | - | - | - | - | - | 0 | 0 | - | 5,696 |
Proceeds from note payable, net of debt issuance costs | |||||||||
- | - | - | - | - | 2,755 | 2,000 | 886 | - | - |
Repurchase of 3.75% senior notes | |||||||||
- | - | 0 | 0 | 3,160 | 3,000 | 0 | 0 | - | - |
Proceeds from exercise of common stock options and warrants | |||||||||
0 | 251 | 269 | 96 | 165 | 837 | 376 | 39 | - | - |
Principal payments on capital lease obligations | |||||||||
11 | 6 | 0 | 70 | 132 | 64 | 17 | 51 | 32 | 25 |
Payment (recovery) from stockholder, net | |||||||||
- | - | 0 | 36 | - | - | - | - | - | - |
Net cash provided by financing activities | |||||||||
30,449 | 25,333 | 269 | -10 | - | - | - | - | 542 | 7,200 |
Effect of exchange rate on cash, cash equivalents and restricted cash | |||||||||
-714 | -860 | 446 | -301 | - | - | - | - | - | - |
Net increase (decrease) in cash, cash equivalents and restricted cash | |||||||||
3,827 | -13,236 | - | - | - | - | - | - | - | - |
Net cash provided by (used in) financing activities | |||||||||
- | - | - | - | -3,111 | 164,465 | 2,296 | 2,337 | - | - |
Effect of exchange rate on cash and cash equivalents | |||||||||
- | - | - | - | 0 | 0 | - | - | - | - |
Net decrease in cash, cash equivalents and restricted cash | |||||||||
- | - | -39,762 | -20,533 | - | - | - | - | - | - |
Net decrease in cash and cash equivalents | |||||||||
- | - | - | - | -71,692 | 156,782 | - | - | - | - |
Net decrease in cash and cash equivalents | |||||||||
- | - | - | - | - | - | -435 | -378 | -2,202 | 3,992 |
Supplemental Cash flow information: | |||||||||
Cash payments for interest | |||||||||
5,633 | 7,340 | 5,391 | 5,393 | - | - | - | - | - | - |
Cash payments for interest | |||||||||
- | - | - | - | 5,517 | 178 | 142 | 99 | 120 | 8 |
Cash payments for income taxes | |||||||||
150 | 89 | 126 | 113 | 123 | 23 | -194 | - | - | - |
Cash payments for income taxes | |||||||||
- | - | - | - | - | - | - | -184 | - | - |
Non cash investing and financing transactions: | |||||||||
Reclassification of derivative liability to equity | |||||||||
- | - | - | - | 18,256 | 0 | 0 | - | - | - |
Acquisition of capital expenditures in accounts payable and accrued expenses | |||||||||
46 | 568 | 3,186 | 1,805 | 0 | - | - | - | - | - |
Capitalized stock compensation in capital expenditures | |||||||||
28 | 96 | 127 | 91 | 0 | - | - | - | - | - |
Issuance of stock to consultant | |||||||||
0 | 102 | 0 | 189 | 31 | 0 | 0 | - | - | - |
Issuance of restricted stock | |||||||||
- | - | - | - | - | - | - | 1 | 2 | 10 |
Bifurcation of derivative from convertible 3.75% senior notes | |||||||||
- | - | - | - | - | 41,400 | 0 | 0 | - | - |
Payable related to product acquisition costs | |||||||||
- | - | - | - | - | 6,000 | 0 | 0 | - | - |
Cash receipt from taxes, net | |||||||||
- | - | - | - | - | - | - | - | -226 | -222 |
Conversion of Series B-1 Convertible Preferred Stock and accrued dividends into Common Stock | |||||||||
- | - | - | - | - | - | - | - | - | 7,136 |
Equipment financed through capital lease | |||||||||
- | - | - | - | - | - | 20 | 30 | - | 122 |
Restricted stock forfeiture | |||||||||
- | - | - | - | - | - | - | 2 | -1 | -7 |
Issuance of warrants | |||||||||
- | - | - | - | - | - | - | 209 | - | 723 |
Debt issuance costs accrued | |||||||||
- | - | - | - | - | - | - | - | - | 74 |
2021 Term Loan | |||||||||
Proceeds from term loan | |||||||||
0 | 25,000 | 0 | 0 | - | - | - | - | - | - |
2023 Term Loan | |||||||||
Proceeds from term loan | |||||||||
10,000 | 70,000 | 0 | 0 | - | - | - | - | - | - |